Age 0 3 0 3 B-age
≥18 4 7 4 7 O
to 8 10 8 10 O
≤75 11 14 11 14 O
years 15 20 15 20 I-upper_bound
at 21 23 21 23 O
time 24 28 24 28 O
of 29 31 29 31 O
consent 32 39 32 39 O

Corrected 0 9 40 49 O
DLCO 10 14 50 54 B-clinical_variable
≥50 15 18 55 58 O
% 18 19 58 59 I-lower_bound

Diffuse 0 7 60 67 B-cancer
large 8 13 68 73 I-cancer
B 14 15 74 75 I-cancer
cell 16 20 76 80 I-cancer
lymphoma 21 29 81 89 I-cancer

Follicular 0 10 90 100 B-cancer
lymphoma 11 19 101 109 I-cancer
( 20 21 110 111 O
any 21 24 111 114 O
grade 25 30 115 120 O
) 30 31 120 121 O

Karnofsky 0 9 122 131 B-clinical_variable
performance 10 21 132 143 I-clinical_variable
status 22 28 144 150 I-clinical_variable
of 29 31 151 153 O
at 32 34 154 156 O
least 35 40 157 162 O
70 41 43 163 165 B-lower_bound
% 43 44 165 166 I-lower_bound

Left 0 4 167 171 B-clinical_variable
ventricular 5 16 172 183 I-clinical_variable
ejection 17 25 184 192 I-clinical_variable
fraction 26 34 193 201 I-clinical_variable
≥45 35 38 202 205 O
% 38 39 205 206 I-lower_bound

Mantle 0 6 207 213 B-cancer
cell 7 11 214 218 I-cancer
lymphoma 12 20 219 227 I-cancer

Multiple 0 8 228 236 B-cancer
myeloma 9 16 237 244 I-cancer
should 17 23 245 251 O
be 24 26 252 254 O
in 27 29 255 257 O
first 30 35 258 263 O
or 36 38 264 266 O
second 39 45 267 273 O
partial 46 53 274 281 O
response 54 62 282 290 O
or 63 65 291 293 O
better 66 72 294 300 O
, 72 73 300 301 O
as 74 76 302 304 O
defined 77 84 305 312 O
by 85 87 313 315 O
International 88 101 316 329 O
Myeloma 102 109 330 337 O
Working 110 117 338 345 O
Group 118 123 346 351 O
criteria.50 124 135 352 363 O

Non 0 3 364 367 B-cancer
- 3 4 367 368 I-cancer
Hodgkin 4 11 368 375 I-cancer
's 11 13 375 377 I-cancer
lymphoma 14 22 378 386 I-cancer
must 23 27 387 391 O
be 28 30 392 394 O
in 31 33 395 397 O
either 34 40 398 404 O
first 41 46 405 410 O
or 47 49 411 413 O
second 50 56 414 420 O
partial 57 64 421 428 O
response 65 73 429 437 O
or 74 76 438 440 O
better 77 83 441 447 O

Patients 0 8 448 456 O
must 9 13 457 461 O
be 14 16 462 464 O
at 17 19 465 467 O
least 20 25 468 473 O
2 26 27 474 475 B-lower_bound
weeks 28 33 476 481 I-lower_bound
from 34 38 482 486 O
last 39 43 487 491 O
treatment 44 53 492 501 B-treatment
with 54 58 502 506 I-treatment
a 59 60 507 508 I-treatment
proteasome 61 71 509 519 I-treatment
inhibitor 72 81 520 529 I-treatment
( 82 83 530 531 O
e.g. 83 87 531 535 O
, 87 88 535 536 O
bortezomib 89 99 537 547 B-treatment
, 99 100 547 548 O
carfilzomib 101 112 549 560 B-treatment
) 112 113 560 561 O
at 114 116 562 564 O
time 117 121 565 569 O
of 122 124 570 572 O
treatment 125 134 573 582 O
on 135 137 583 585 O
this 138 142 586 590 O
protocol 143 151 591 599 O

Patients 0 8 600 608 O
must 9 13 609 613 O
be 14 16 614 616 O
at 17 19 617 619 O
least 20 25 620 625 O
4 26 27 626 627 B-lower_bound
weeks 28 33 628 633 I-lower_bound
from 34 38 634 638 O
last 39 43 639 643 O
cytotoxic 44 53 644 653 B-treatment
chemotherapy 54 66 654 666 I-treatment
( 67 68 667 668 O
including 68 77 668 677 O
alkylating 78 88 678 688 B-treatment
, 88 89 688 689 O
anthracyclines 90 104 690 704 B-treatment
, 104 105 704 705 O
epipodophylatoxins 106 124 706 724 B-treatment
, 124 125 724 725 O
and 126 129 726 729 O
platinum 130 138 730 738 B-treatment
drugs 139 144 739 744 I-treatment
) 144 145 744 745 O
, 145 146 745 746 O
or 147 149 747 749 O
immunomodulatory 150 166 750 766 B-treatment
drugs 167 172 767 772 I-treatment
( 173 174 773 774 O
including 174 183 774 783 O
lenalidomide 184 196 784 796 B-treatment
or 197 199 797 799 O
pomalidomide 200 212 800 812 B-treatment
, 212 213 812 813 O
or 214 216 814 816 O
related 217 224 817 824 O
derivatives 225 236 825 836 O
) 236 237 836 837 O
at 238 240 838 840 O
time 241 245 841 845 O
of 246 248 846 848 O
treatment 249 258 849 858 B-treatment
on 259 261 859 861 O
this 262 266 862 866 O
protocol 267 275 867 875 O

Patients 0 8 876 884 O
must 9 13 885 889 O
be 14 16 890 892 O
negative 17 25 893 901 O
for 26 29 902 905 O
HIV 30 33 906 909 B-chronic_disease

Patients 0 8 910 918 O
must 9 13 919 923 O
have 14 18 924 928 O
a 19 20 929 930 O
previously 21 31 931 941 O
documented 32 42 942 952 O
histologic 43 53 953 963 O
diagnosis 54 63 964 973 O
of 64 66 974 976 O
multiple 67 75 977 985 B-cancer
myeloma 76 83 986 993 I-cancer
( 84 85 994 995 I-cancer
MM 85 87 995 997 I-cancer
) 87 88 997 998 I-cancer
or 89 91 999 1001 O
non 92 95 1002 1005 B-cancer
- 95 96 1005 1006 I-cancer
Hodgkin 96 103 1006 1013 I-cancer
's 103 105 1013 1015 I-cancer
lymphoma 106 114 1016 1024 I-cancer
( 115 116 1025 1026 I-cancer
NHL 116 119 1026 1029 I-cancer
) 119 120 1029 1030 I-cancer
, 120 121 1030 1031 O
and 122 125 1032 1035 O
be 126 128 1036 1038 O
eligible 129 137 1039 1047 O
to 138 140 1048 1050 O
undergo 141 148 1051 1058 O
autologous 149 159 1059 1069 B-treatment
PBSC 160 164 1070 1074 I-treatment
transplantation 165 180 1075 1090 I-treatment
on 181 183 1091 1093 O
institutional 184 197 1094 1107 O
protocols 198 207 1108 1117 O

Patients 0 8 1118 1126 O
must 9 13 1127 1131 O
not 14 17 1132 1135 O
have 18 22 1136 1140 O
a 23 24 1141 1142 O
prior 25 30 1143 1148 B-treatment
autologous 31 41 1149 1159 I-treatment
, 41 42 1159 1160 O
syngeneic 43 52 1161 1170 B-treatment
or 53 55 1171 1173 I-treatment
allogeneic 56 66 1174 1184 I-treatment
hematopoietic 67 80 1185 1198 I-treatment
stem 81 85 1199 1203 I-treatment
cell 86 90 1204 1208 I-treatment
transplant 91 101 1209 1219 I-treatment

Patients 0 8 1220 1228 O
must 9 13 1229 1233 O
not 14 17 1234 1237 O
have 18 22 1238 1242 O
nor 23 26 1243 1246 O
had 27 30 1247 1250 O
active 31 37 1251 1257 O
or 38 40 1258 1260 O
recent 41 47 1261 1267 O
peptic 48 54 1268 1274 B-chronic_disease
ulcer 55 60 1275 1280 I-chronic_disease
disease 61 68 1281 1288 I-chronic_disease
within 69 75 1289 1295 O
the 76 79 1296 1299 O
past 80 84 1300 1304 B-upper_bound
6 85 86 1305 1306 I-upper_bound
months 87 93 1307 1313 I-upper_bound

Patients 0 8 1314 1322 O
must 9 13 1323 1327 O
not 14 17 1328 1331 O
have 18 22 1332 1336 O
received 23 31 1337 1345 O
myeloid 32 39 1346 1353 B-treatment
growth 40 46 1354 1360 I-treatment
factors 47 54 1361 1368 I-treatment
within 55 61 1369 1375 O
2 62 63 1376 1377 B-upper_bound
weeks 64 69 1378 1383 I-upper_bound
before 70 76 1384 1390 O
mobilization 77 89 1391 1403 O
attempt 90 97 1404 1411 O
on 98 100 1412 1414 O
this 101 105 1415 1419 O
study 106 111 1420 1425 O

Patients 0 8 1426 1434 O
must 9 13 1435 1439 O
not 14 17 1440 1443 O
have 18 22 1444 1448 O
received 23 31 1449 1457 O
prior 32 37 1458 1463 B-treatment
bone 38 42 1464 1468 I-treatment
seeking 43 50 1469 1476 I-treatment
radionuclides 51 64 1477 1490 I-treatment

Patients 0 8 1491 1499 O
must 9 13 1500 1504 O
not 14 17 1505 1508 O
have 18 22 1509 1513 O
received 23 31 1514 1522 O
radiation 32 41 1523 1532 B-treatment
therapy 42 49 1533 1540 I-treatment
within 50 56 1541 1547 O
the 57 60 1548 1551 O
past 61 65 1552 1556 B-upper_bound
4 66 67 1557 1558 I-upper_bound
weeks 68 73 1559 1564 I-upper_bound

Patients 0 8 1565 1573 O
must 9 13 1574 1578 O
not 14 17 1579 1582 O
have 18 22 1583 1587 O
taken 23 28 1588 1593 O
nonsteroidal 29 41 1594 1606 B-treatment
antiinflammatory 42 58 1607 1623 I-treatment
drugs 59 64 1624 1629 I-treatment
( 65 66 1630 1631 I-treatment
NSAID 66 71 1631 1636 I-treatment
) 71 72 1636 1637 I-treatment
in 73 75 1638 1640 O
the 76 79 1641 1644 O
past 80 84 1645 1649 B-upper_bound
14 85 87 1650 1652 I-upper_bound
days 88 92 1653 1657 I-upper_bound
before 93 99 1658 1664 O
treatment 100 109 1665 1674 O
on 110 112 1675 1677 O
this 113 117 1678 1682 O
protocol 118 126 1683 1691 O

Patients 0 8 1692 1700 O
with 9 13 1701 1705 O
a 14 15 1706 1707 O
history 16 23 1708 1715 O
of 24 26 1716 1718 O
asthma 27 33 1719 1725 B-chronic_disease
will 34 38 1726 1730 O
be 39 41 1731 1733 O
excluded 42 50 1734 1742 O
because 51 58 1743 1750 O
of 59 61 1751 1753 O
the 62 65 1754 1757 O
potential 66 75 1758 1767 O
for 76 79 1768 1771 O
NSAID 80 85 1772 1777 B-treatment
to 86 88 1778 1780 O
precipitate 89 100 1781 1792 O
asthma 101 107 1793 1799 O
in 108 110 1800 1802 O
these 111 116 1803 1808 O
patients 117 125 1809 1817 O

Peripheral 0 10 1818 1828 B-cancer
T 11 12 1829 1830 I-cancer
cell 13 17 1831 1835 I-cancer
lymphoma 18 26 1836 1844 I-cancer

Serum 0 5 1845 1850 B-clinical_variable
bilirubin 6 15 1851 1860 I-clinical_variable
, 15 16 1860 1861 O
AST 17 20 1862 1865 B-clinical_variable
( 21 22 1866 1867 I-clinical_variable
aspartate 22 31 1867 1876 I-clinical_variable
aminotransferase 32 48 1877 1893 I-clinical_variable
) 48 49 1893 1894 I-clinical_variable
and 50 53 1895 1898 O
ALT(alanine 54 65 1899 1910 B-clinical_variable
aminotransferase 66 82 1911 1927 I-clinical_variable
) 82 83 1927 1928 I-clinical_variable
≤ 84 85 1929 1930 O
twice 86 91 1931 1936 B-upper_bound
the 92 95 1937 1940 I-upper_bound
upper 96 101 1941 1946 I-upper_bound
limit 102 107 1947 1952 I-upper_bound
of 108 110 1953 1955 I-upper_bound
normal 111 117 1956 1962 I-upper_bound

Serum 0 5 1963 1968 B-clinical_variable
creatinine 6 16 1969 1979 I-clinical_variable
≤ 17 18 1980 1981 O
2.0 19 22 1982 1985 B-upper_bound
mg 23 25 1986 1988 I-upper_bound
/ 25 26 1988 1989 I-upper_bound
dl 26 28 1989 1991 I-upper_bound

Transformed 0 11 1992 2003 O
lymphoma 12 20 2004 2012 B-cancer

Urine 0 5 2013 2018 B-clinical_variable
M 6 7 2019 2020 I-clinical_variable
- 7 8 2020 2021 I-clinical_variable
protein 8 15 2021 2028 I-clinical_variable
≤1 16 18 2029 2031 O
g/24 19 23 2032 2036 I-upper_bound
hours 24 29 2037 2042 O
( 30 31 2043 2044 O
MM 31 33 2044 2046 O
patients 34 42 2047 2055 O
only 43 47 2056 2060 O
) 47 48 2060 2061 O

Women 0 5 2062 2067 B-gender
and 6 9 2068 2071 O
men 10 13 2072 2075 O
must 14 18 2076 2080 O
use 19 22 2081 2084 B-contraception_consent
adequate 23 31 2085 2093 I-contraception_consent
birth 32 37 2094 2099 I-contraception_consent
control 38 45 2100 2107 I-contraception_consent
while 46 51 2108 2113 O
taking 52 58 2114 2120 O
part 59 63 2121 2125 O
in 64 66 2126 2128 O
this 67 71 2129 2133 O
study 72 77 2134 2139 O
( 78 79 2140 2141 O
such 79 83 2141 2145 O
as 84 86 2146 2148 O
a 87 88 2149 2150 O
condom 89 95 2151 2157 B-contraception_consent
or 96 98 2158 2160 O
diaphragm 99 108 2161 2170 B-contraception_consent
with 109 113 2171 2175 I-contraception_consent
contraceptive 114 127 2176 2189 I-contraception_consent
cream 128 133 2190 2195 I-contraception_consent
/ 133 134 2195 2196 I-contraception_consent
jelly 134 139 2196 2201 I-contraception_consent
, 139 140 2201 2202 O
birth 141 146 2203 2208 B-contraception_consent
control 147 154 2209 2216 I-contraception_consent
pills 155 160 2217 2222 I-contraception_consent
, 160 161 2222 2223 O
Norplant 162 170 2224 2232 B-contraception_consent
, 170 171 2232 2233 O
abstinence 172 182 2234 2244 B-contraception_consent
( 183 184 2245 2246 I-contraception_consent
no 184 186 2246 2248 I-contraception_consent
sexual 187 193 2249 2255 I-contraception_consent
intercourse 194 205 2256 2267 I-contraception_consent
) 205 206 2267 2268 I-contraception_consent
or 207 209 2269 2271 O
surgical 210 218 2272 2280 B-contraception_consent
sterilization 219 232 2281 2294 I-contraception_consent

Women 0 5 2295 2300 B-gender
of 6 8 2301 2303 O
childbearing 9 21 2304 2316 O
potential 22 31 2317 2326 O
must 32 36 2327 2331 O
have 37 41 2332 2336 O
a 42 43 2337 2338 O
negative 44 52 2339 2347 B-pregnancy
pregnancy 53 62 2348 2357 I-pregnancy
test 63 67 2358 2362 O
( 68 69 2363 2364 O
urine 69 74 2364 2369 O
or 75 77 2370 2372 O
serum 78 83 2373 2378 O
) 83 84 2378 2379 O

not 0 3 2380 2383 O
to 4 6 2384 2386 O
more 7 11 2387 2391 O
than 12 16 2392 2396 O
20 17 19 2397 2399 B-upper_bound
% 19 20 2399 2400 I-upper_bound
of 21 23 2401 2403 O
hematopoiesis 24 37 2404 2417 O
forming 38 45 2418 2425 O
bones 46 51 2426 2431 O
( 52 53 2432 2433 O
spine 53 58 2433 2438 O
, 58 59 2438 2439 O
pelvis 60 66 2440 2446 O
and 67 70 2447 2450 O
proximal 71 79 2451 2459 O
long 80 84 2460 2464 O
bones 85 90 2465 2470 O
) 90 91 2470 2471 O

